−Removed: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
−Removed: cash and cash equivalents include all highly liquid investments with an original maturity of three months or less.
−Removed: Our cash equivalents
−Removed: are in a money market account.
−Removed: Because of the short-term maturities of our cash and cash equivalents, we do not believe that an
−Removed: increase in market rates would have a significant impact on the realized value of our investments.
−Removed: We place our cash and cash
−Removed: equivalents on deposit with financial institutions in the United States.
−Removed: The Federal Deposit Insurance Corporation limits coverage
−Removed: for all depository accounts.
−Removed: Our cash and cash equivalents at times may exceed covered limits.
−Removed: currency exchange risk
−Removed: currently have limited, but may in the future have increased, clinical and commercial manufacturing agreements which are denominated
−Removed: in Euros or other foreign currencies.
−Removed: As a result, our financial results could be affected by factors such as a change in the
−Removed: foreign currency exchange rate between the U.S.
−Removed: dollar and the Euro or other applicable currencies, or by weak economic conditions
−Removed: in Europe or elsewhere in the world.
−Removed: We are not currently engaged in any foreign currency hedging activities.
−Removed: indexed security risk
−Removed: have issued warrants to various holders underlying shares of our common stock.
−Removed: These warrants are re-measured to their fair value
−Removed: at each reporting period with changes in their fair value recorded as derivative gain (loss) in the accompanying consolidated
−Removed: statement of operations.
−Removed: We use the Black-Scholes model for valuation of the warrants.
+Added: QUANTITATIVE AND QUALITATIVE
+Added: DISCLOSURES ABOUT MARKET RISK
+Added: Interest rate risk
+Added: Our cash and cash equivalents include all highly
+Added: liquid investments with an original maturity of three months or less.
+Added: Our cash equivalents are in a money market account.
+Added: Because of the
+Added: short-term maturities of our cash and cash equivalents, we do not believe that an increase in market rates would have a significant impact
+Added: on the realized value of our investments.
+Added: We place our cash and cash equivalents on deposit with financial institutions in the United
+Added: The Federal Deposit Insurance Corporation limits coverage for all depository accounts.
+Added: Our cash and cash equivalents at times
+Added: may exceed covered limits.
+Added: Foreign currency exchange risk
+Added: We currently have limited, but may in the future
+Added: have increased, clinical and commercial manufacturing agreements which are denominated in Euros or other foreign currencies.
+Added: our financial results could be affected by factors such as a change in the foreign currency exchange rate between the U.S.
+Added: the Euro or other applicable currencies, or by weak economic conditions in Europe or elsewhere in the world.
+Added: We are not currently engaged
+Added: in any foreign currency hedging activities.
+Added: Market indexed security risk
+Added: We have issued warrants to various holders underlying
+Added: shares of our common stock.
+Added: These warrants are re-measured to their fair value at each reporting period with changes in their fair value
+Added: recorded as derivative gain (loss) in the accompanying consolidated statement of operations.
+Added: We use the Black-Scholes model for valuation
+Added: of the warrants.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.